Author:
Glatt Hansruedi,Hirom Paul C.,Kirkby Charles A.,Ribeiro Odartey,Seidel Albrecht,Oesch Franz
Reference15 articles.
1. I. S. Owens, C. Legraverend and O. Pelkonen, Deoxyribonucleic acid binding of 3-hydroxy-and 9-hydroxybenzo[a]pyrene following further metabolism by mouse liver microsomal cytochrome P1-450, Biochem. Pharmacol, 28:1623 (1979).
2. J. Capdevila, B. Jernström, H. Vadi and S. Orrenius, Cytochrome P-450-linked activation of 3-hydroxybenzo[a]pyrene, Biochem. Biophys. Res. Commun. 65:894 (1975).
3. I. S. Owens, G. M. Koteen and C. Legraverend, Mutagenesis of certain benzo[a]pyrene phenols in vitro following further metabolism by mouse liver, Biochem. Pharmacol. 28:1615 (1979).
4. H. R. Glatt, R. Billings, K. L. Platt and F. Oesch, Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo-[a]pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate, Cancer Res. 41:270 (1981).
5. O. Ribeiro, C. A. Kirkby, P. C. Hirom and P. Millburn, Secondary metabolites of benzo[a]pyrene: 3-hydroxy-trans-7,8-dihydro-7,8-di-hydroxybenzo[a]pyrene, a biliary metabolite of 3-hydroxybenzo[a]-pyrene in the rat, Carcinogenesis 6:1507 (1985).